Imports vs. no drugsThe opposing view on drug re-importation by William Hubbard, associate commissioner of the U.S. Food and Drug Administration, mentions a patient who was harmed by imported drugs ("Risks are too high", High prescription costs debate, Aug. 23). But how many patients are harmed when they can't afford drugs because of the ban on
(
Read more... )